IP Library Granted Patent US 7,776,532
Granted Patent B2
US 7,776,532 · App. 11/502,624 · Granted Aug 17, 2010

Method for in vitro recombination

Assignee: Synthetic Genomics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,776,532
App. No.
11/502,624
Granted
Aug 17, 2010
Kind
B2
Abstract

The present invention relates, e.g., to an in vitro method, using isolated protein reagents, for joining two double-stranded (ds) DNA molecules of interest, wherein the distal region of the first DNA molecule and the proximal region of the second DNA molecule share a region of sequence identity, comprising (a) chewing back the DNA molecules with an enzyme having an exonuclease activity, to yield single-stranded overhanging portions of each DNA molecule which contain a sufficient length of the region of sequence identity to hybridize specifically to each other; (b) specifically annealing the single-stranded overhangs; and (c) repairing single-stranded gaps in the annealed DNA molecules and sealing the nicks thus formed (ligating the nicked DNA molecules). The region of sequence identity generally comprises at least 20 non-palindromic nucleotides (nt), e.g., at least about 40 non-palindromic nt. In some embodiments of the invention, about 5% PEG is present during all steps of the reaction, and/or the repair reaction is achieved with Taq DNA polymerase and a compatible ligase, such as Taq DNA ligase. The method allows the joining of a number of DNA fragments, in a predetermined order and orientation, without the use of restriction enzymes. It can be used, e.g., to join synthetically produced sub-fragments of a gene or genome of interest.

Claims (40)

1. An in vitro method for joining a first set of double-stranded (ds) DNA molecules, comprising:

(a) providing two or more dsDNA molecules to be joined in a reaction mixture, wherein, for each pair of dsDNA molecules to be joined, a distal region of a first DNA molecule and a proximal region of a second DNA molecule share a region of sequence homology;

(b) treating the provided dsDNA molecules with a substantially purified enzyme having 3′-5′ exonuclease activity, whereby a single-stranded overhanging portion is generated in each of the dsDNA molecules by 3′-5′ exonuclease digestion, wherein each overhanging portion contains the region of homology or a portion thereof sufficient to specifically anneal to the overhanging portion in the other molecule of the pair;

(c) incubating the DNA molecules generated in step (b), under conditions whereby they anneal through the regions of homology or portions thereof; and

(d) treating the annealed molecules with a substantially purified polymerase and a substantially purified compatible ligase, under conditions whereby remaining single-stranded gap(s) are filled in by the polymerase and nicks are sealed by the ligase;

thereby joining the dsDNA molecules, wherein a crowding agent is present in the reaction mixture during each of steps (b), (c), and (d).

2. The method of claim 1 , wherein the crowding agent is PEG.

3. The method of claim 2 , wherein the concentration of PEG in the reaction mixture is about 5% PEG.

4. The method of claim 1 , wherein the polymerase in step (d) is Taq DNA polymerase.

5. The method of claim 1 , wherein the compatible ligase in step (d) is Taq ligase.

6. The method of claim 1 , wherein the enzyme having 3′-5′ exonuclease activity is a DNA polymerase that exhibits exonuclease activity when incubated in the absence of dNTPs.

7. The method of claim 1 , wherein the enzyme having 3′-5′ exonuclease activity is selected from the group consisting of T4 DNA polymerase, T7 DNA polymerase, DNA polymerase I, Klenow DNA polymerase, Phi 29 DNA polymerase, Pfu polymerase, Phusion™ High-Fidelity polymerase, exonuclease III, Vent R ®, Deep Vent R ® and 9° N m ™ DNA polymerase.

8. The method of claim 1 , wherein the enzyme having 3′-5′exonuclease activity is T4 DNA polymerase.

9. The method of claim 1 , wherein the incubating in step (c) is carried out by subjecting the molecules to conditions effective to separate any single-stranded portions that have annealed and, optionally, to inactivate the enzyme having 3′-5′ exonuclease activity, followed by slowly cooling the molecules to about 24° C. or less, under conditions effective to allow the single-stranded overhanging portions to anneal.

10. The method of claim 9 , wherein subjecting the molecules to conditions effective to separate any annealed portions and, optionally, to inactivate the enzyme having 3′-5′ exonuclease activity, includes heating said molecules to 75° C. plus or minus 5° C.

11. The method of claim 1 , wherein the treating in step (d) is performed at between 45° C. and 55° C.

12. The method of claim 1 , wherein the incubation in step (c) is carried out in the presence of a protein that enhances the binding of single-stranded overhanging portions containing homologous regions or portions thereof.

13. The method of claim 12 , wherein the protein that enhances the binding of the single-stranded overhanging portions is recA, E. coli single-stranded binding protein (SSB), T7 SSB (T7 gene 2.5 product), or T4 gene 32 protein.

14. The method of claim 1 , wherein at least four dsDNA molecules are joined and each shared region of sequence homology is unique for each pair of DNA molecules joined.

15. The method of claim 14 , wherein at least eight dsDNA molecules are joined.

16. The method of claim 1 , wherein the DNA molecules to be joined are at least about 5 kb in length.

17. The method of claim 16 , wherein the DNA molecules to be joined are at least about 140 kb in length.

18. The method of claim 17 , wherein the DNA molecules to be joined are at least about 500 kb in length.

19. The method of claim 1 , wherein, for at least one pair of dsDNA molecules to be joined, the region of sequence homology comprises at least about 20 non-palindromic nucleotides in length.

20. The method of claim 1 , wherein, for at least one pair of dsDNA molecules to be joined, the region of sequence homology comprises at least about 300 nucleotides in length.

21. The method of claim 1 , wherein steps (b) through (d) are carried out in a single reaction vessel.

22. The method of claim 1 , further comprising:

(i) joining a second set of dsDNA molecules by performing steps (a) through (d); and

(ii) performing a second stage assembly, comprising steps (a) through (d), wherein the dsDNA molecules provided in step (a) comprise a product produced by joining the first set and a product produced by joining the second set.

23. The method of claim 1 , wherein the method is automated and high-throughput.

24. The method of claim 1 , wherein a PCI clean-up procedure is not carried out following the exonuclease digestion.

25. The method of claim 1 , wherein the overhanging portions are generated without the use of a restriction enzyme.

26. The method of claim 1 , wherein the dsDNA molecules are joined in a predefined order and orientation.

27. The method of claim 1 , wherein steps (b) and (c) are performed in the same reaction mixture, containing the same buffer and reaction components.

28. The method of claim 1 , wherein steps (b) and (c) are performed in the same reaction vessel and the vessel is not opened between steps (b) and (c).

29. The method of claim 1 , wherein the crowding agent is a polymer selected from the group consisting of PEG, Ficoll, and dextran.

30. The method of claim 2 , wherein the size of the PEG is within the range of PEG 4,000 to PEG 20,000.

31. The method of claim 30 , wherein the PEG is PEG 8,000.

32. The method of claim 1 , wherein the treating in step (d) is performed at between 37° C. and 75° C.

33. The method of claim 1 , wherein the treating in step (d) is performed at 37° C.

Assignments (12)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
CHANGE OF NAME Recorded Apr 19, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063379/0581 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
CHANGE OF NAME Recorded May 19, 2020
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 052705/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 049602/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2009
From: J. CRAIG VENTER INSTITUTE, INC.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 022905/0045 →
CONFIRMATORY LICENSE Recorded May 4, 2007
From: J. CRAIG VENTER INSTITUTE, INC.
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 019252/0900 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF 2ND INVENTOR FROM HAMILSON TO HAMILTON PREVIOUSLY RECORDED ON REEL 018368 FRAME 0777. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF U.S. PATENT APPLICATION SERIAL NO. 11/502,624 FILED ON AUG. 11, 2006 TO J. CRAIG VENTER INSTITUTE, INC.. Recorded Nov 8, 2006
From: GIBSON, DANIEL GLENN; SMITH, HAMILTON O.
To: J. CRAIG VENTER INSTITUTE, INC.
Reel/Frame 018496/0318 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2006
From: GIBSON, DANIEL GLENN; SMITH, HAMILSON O.
To: J. CRAIG VENTER INSTITUTE, INC., THE
Reel/Frame 018368/0777 →
Continuity (3)
Provisional Application 6070717700 · Aug 11, 2005
Provisional Application 6080040000 · May 16, 2006
Related Publication 20070037196A1 · Feb 15, 2007